Abstract:e15531 Background: Persistent inflammatory diseases such as ulcerative colitis (UC) and Crohn’s disease (CD) contribute to the tumor initiation and progression in colitis-associated cancers (CAC). Intestinal damage caused by persistent inflammation promotes clonal expansion of somatic and epithelial cells and alters the immune microenvironment. A comprehensive investigation in comparing the tumor immune environment in CAC with sporadic colorectal cancers (CRC) will provide more clinical usefulness of immunoprofiling in CRC. Methods: Thirteen patients with CAC (6 with UC and 7 with CD) and 10 patients with sporadic colorectal cancer from our hospital were enrolled in the study. FFPE samples from patients were analyzed for the tumor infiltrating lymphocytes [PD-L1+, CD3+, CD4+, CD8+, CD20+, CD68+, CD163+] by multiplex immunofluorescence technique. The core and peritumor areas annotated by pathologists on images. Then artificial intelligence (AI) algorithms delineated the tumor-enriched segments and stroma, and calculated the density and percentage of each marker in two regions. A nonparametric approach (Kruskal–Wallis) was used to compare the density and percentage of immune cells between CAC and sporadic colorectal cancer groups. Results: In the stroma area, the density (counts per mm 2 ) of PD-L1+CD68+ cells in patients with CAC were significantly higher than those in sporadic cancer patients (p < 0.05). However, the density of PD-L1+CD68+ did not show significant differences related to disease types (CAC or sporadic CRC) in the tumor-enriched segments. Significantly, the density of CD3+CD4+ cells and the percentage of CD68+CD163- cells in patients with CAC showed a trend of higher density than those in sporadic cancer patients in the stroma area (all, 0.05 < p < 0.1). The density and the percentage of CD20+ cells in CAC patients had a higher density tendency than those in sporadic cancer patients both in the tumor-enriched segments and stroma (all, 0.05 < p < 0.1). Other indicators in tumor-enriched segments and stroma, such as CD3+, CD4+, CD8+, CD68+CD163+ and PD-L1+, had no significant difference between CAC and sporadic CRC patients, regardless of the percentage or the density. Conclusions: We identified that the tumor immune environment of CAC was different from that of sporadic CRC. Some tumor infiltrating lymphocytes such as PD-L1+CD68+ cells infiltrated more in CAC than those in sporadic cancer, suggesting that CAC may respond better to immunotherapy than sporadic CRC. However, this hypothesis requires a further validation with a larger sample size.

Mutational analysis differentiating sporadic carcinomas from colitis-associated colorectal carcinomas

Molecular characterization of ulcerative colitis-associated colorectal carcinomas

An Overview of Molecular Profiles in Ulcerative Colitis–Related Cancer

KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis

P234 Differentiation of histopathological features between sporadic and colitis-associated colorectal cancer in a nationwide large cohort

Relative role of methylator and tumor suppressor pathways in ulcerative colitis-associated colon cancer

Prognosis of Ulcerative Colitis-Associated Colorectal Carcinoma Compared to Sporadic Colorectal Carcinoma: A Matched Pair Analysis

Tumor immune environment in colitis-associated colorectal cancers: Comparison with sporadic colorectal cancers.

Digital spatial profiling identifies molecular changes involved in development of colitis-associated colorectal cancer

Colitis-associated neoplasia: molecular basis and clinical translation

Colorectal cancer in Crohn’s colitis is associated with advanced tumor invasion and a poorer survival compared with ulcerative colitis: a retrospective dual-center study

Somatic mutation profiles as molecular classifiers of ulcerative colitis‐associated colorectal cancer

Molecular mechanisms in colitis-associated colorectal cancer

Differential Immune Infiltration Profiles in Colitis-Associated Colorectal Cancer versus Sporadic Colorectal Cancer

Molecular Pathogenesis of Colitis-associated Colorectal Cancer: Immunity, Genetics, and Intestinal Microecology

Histological differentiation between sporadic and colitis‐associated intestinal cancer in a nationwide study: A propensity‐score‐matched analysis

[Ulcerative colitis-associated carcinogenesis : An update]

The risk of colorectal cancer in patients with ulcerative colitis

Alterations in p53, Microsatellite Stability and Lack of MUC5AC Expression as Molecular Features of Colorectal Carcinoma Associated with Inflammatory Bowel Disease

Comparative Mutational Analysis of Distal Colon Cancer with Rectal Cancer.

Differences in Prognosis and Recurrence Patterns Between Ulcerative Colitis-Associated Colorectal Cancer and Sporadic Colorectal Cancer: A Matched-Pair Analysis